27485101|t|MicroRNA-26a protects against cardiac hypertrophy via inhibiting GATA4 in rat model and cultured cardiomyocytes.
27485101|a|Pathological cardiac hypertrophy is characterized by deleterious changes developed in cardiovascular diseases, whereas microRNAs (miRNAs) are involved in the mediation of cardiac hypertrophy. To investigate the role of microRNA-26a (miR-26a) in regulating cardiac hypertrophy and its functioning mechanisms, overexpression and suppression of miR-26a via its mimic and inhibitor in a transverse abdominal aortic constriction (TAAC)- induced rat model and in angiotensin II (Ang II)- induced cardiomyocytes (CMs) was performed. In the rat model, the heart weight (HW) compared with the body weight (BW), the CM area, and expression of the hypertrophy - associated factors, atrial natriuretic factor (ANF) and ß-myosin heavy chain (ß-MHC), were assessed. In CMs, the protein synthesis rate was determined using a leucine incorporation assay. Mutation of the GATA-binding protein 4 (GATA4) 3'-untranslated region (UTR) and overexpression of GATA4 were performed to confirm whether GATA4 is the target of miR-26a. The results indicated that miR-26a was significantly downregulated in the heart tissue of the rat model, as well as in Ang II - induced CMs (P<0.05). The TAAC - induced rat model exhibited a higher HW / BW ratio, a larger CM area, and higher expression levels of ANF and ß-MHC. CMs, upon Ang II treatment, also demonstrated a larger CM area, higher levels of ANF and ß-MHC, as well as accelerated protein synthesis. miR-26a was not able to regulate GATA4 with mutations in the 3'-UTR, indicating that GATA4 was the direct target of miR-26a. Overexpression of GATA4 abrogated the inhibitory functions of miR-26a in cardiac hypertrophy. Taken together, the present study suggested an anti-hypertrophic role of miR-26a in cardiac hypertrophy, possibly via inhibition of GATA4. These findings may be useful in terms of facilitating cardiac treatment, with potential therapeutic targets and strategies.
27485101	0	12	MicroRNA-26a	T103	UMLS:C3179934
27485101	30	49	cardiac hypertrophy	T038	UMLS:C1383860
27485101	65	70	GATA4	T017	UMLS:C1414995
27485101	74	77	rat	T204	UMLS:C0034721
27485101	78	83	model	T204	UMLS:C0599779
27485101	88	111	cultured cardiomyocytes	T017	UMLS:C0007635
27485101	97	111	cardiomyocytes	T017	UMLS:C0225828
27485101	126	145	cardiac hypertrophy	T038	UMLS:C1383860
27485101	199	222	cardiovascular diseases	T038	UMLS:C0007222
27485101	232	241	microRNAs	T103	UMLS:C1101610
27485101	243	249	miRNAs	T103	UMLS:C1101610
27485101	284	303	cardiac hypertrophy	T038	UMLS:C1383860
27485101	332	344	microRNA-26a	T103	UMLS:C3179934
27485101	346	353	miR-26a	T103	UMLS:C3179934
27485101	358	388	regulating cardiac hypertrophy	T038	UMLS:C2611906
27485101	397	408	functioning	T038	UMLS:C0232164
27485101	421	435	overexpression	T038	UMLS:C0017262
27485101	440	451	suppression	T038	UMLS:C0038855
27485101	455	462	miR-26a	T017	UMLS:C2825314
27485101	471	476	mimic	T038	UMLS:C0242943
27485101	481	490	inhibitor	T103	UMLS:C0243077
27485101	496	506	transverse	T082	UMLS:C0205106
27485101	507	516	abdominal	T082	UMLS:C0000726
27485101	553	556	rat	T204	UMLS:C0034721
27485101	557	562	model	T204	UMLS:C0599779
27485101	570	584	angiotensin II	T103	UMLS:C0003009
27485101	586	592	Ang II	T103	UMLS:C0003009
27485101	603	617	cardiomyocytes	T017	UMLS:C0225828
27485101	619	622	CMs	T017	UMLS:C0225828
27485101	646	649	rat	T204	UMLS:C0034721
27485101	650	655	model	T204	UMLS:C0599779
27485101	719	721	CM	T017	UMLS:C0225828
27485101	722	726	area	T082	UMLS:C0205146
27485101	750	761	hypertrophy	T038	UMLS:C0020564
27485101	784	809	atrial natriuretic factor	T103	UMLS:C0027481
27485101	811	814	ANF	T103	UMLS:C0027481
27485101	820	840	ß-myosin heavy chain	T103	UMLS:C1451796
27485101	842	847	ß-MHC	T103	UMLS:C1451796
27485101	868	871	CMs	T017	UMLS:C0225828
27485101	877	894	protein synthesis	T038	UMLS:C0597295
27485101	923	950	leucine incorporation assay	T058	UMLS:C0005507
27485101	952	960	Mutation	T038	UMLS:C0026882
27485101	968	990	GATA-binding protein 4	T017	UMLS:C1414995
27485101	992	997	GATA4	T017	UMLS:C1414995
27485101	999	1021	3'-untranslated region	T082	UMLS:C0600600
27485101	1023	1026	UTR	T082	UMLS:C0600600
27485101	1032	1046	overexpression	T038	UMLS:C1514559
27485101	1050	1055	GATA4	T017	UMLS:C1414995
27485101	1090	1095	GATA4	T017	UMLS:C1414995
27485101	1113	1120	miR-26a	T103	UMLS:C3179934
27485101	1149	1156	miR-26a	T103	UMLS:C3179934
27485101	1175	1188	downregulated	T038	UMLS:C0013081
27485101	1196	1208	heart tissue	T017	UMLS:C1272575
27485101	1216	1219	rat	T204	UMLS:C0034721
27485101	1220	1225	model	T204	UMLS:C0599779
27485101	1241	1247	Ang II	T103	UMLS:C0003009
27485101	1258	1261	CMs	T017	UMLS:C0225828
27485101	1291	1294	rat	T204	UMLS:C0034721
27485101	1295	1300	model	T204	UMLS:C0599779
27485101	1344	1346	CM	T017	UMLS:C0225828
27485101	1347	1351	area	T082	UMLS:C0205146
27485101	1364	1374	expression	T038	UMLS:C1171362
27485101	1385	1388	ANF	T103	UMLS:C0027481
27485101	1393	1398	ß-MHC	T103	UMLS:C1451796
27485101	1400	1403	CMs	T017	UMLS:C0225828
27485101	1410	1416	Ang II	T103	UMLS:C0003009
27485101	1417	1426	treatment	T058	UMLS:C0087111
27485101	1455	1457	CM	T017	UMLS:C0225828
27485101	1458	1462	area	T082	UMLS:C0205146
27485101	1481	1484	ANF	T103	UMLS:C0027481
27485101	1489	1494	ß-MHC	T103	UMLS:C1451796
27485101	1519	1536	protein synthesis	T038	UMLS:C0597295
27485101	1538	1545	miR-26a	T103	UMLS:C3179934
27485101	1562	1570	regulate	T038	UMLS:C1327622
27485101	1571	1576	GATA4	T017	UMLS:C1414995
27485101	1582	1591	mutations	T038	UMLS:C0026882
27485101	1599	1605	3'-UTR	T082	UMLS:C0600600
27485101	1623	1628	GATA4	T017	UMLS:C1414995
27485101	1654	1661	miR-26a	T103	UMLS:C3179934
27485101	1663	1677	Overexpression	T038	UMLS:C1514559
27485101	1681	1686	GATA4	T017	UMLS:C1414995
27485101	1701	1721	inhibitory functions	T038	UMLS:C0234122
27485101	1725	1732	miR-26a	T103	UMLS:C3179934
27485101	1736	1755	cardiac hypertrophy	T038	UMLS:C1383860
27485101	1804	1821	anti-hypertrophic	T033	UMLS:C0243095
27485101	1830	1837	miR-26a	T103	UMLS:C3179934
27485101	1841	1860	cardiac hypertrophy	T038	UMLS:C1383860
27485101	1889	1894	GATA4	T017	UMLS:C1414995
27485101	1902	1910	findings	T033	UMLS:C0243095
27485101	1950	1957	cardiac	T017	UMLS:C0018787
27485101	1958	1967	treatment	T058	UMLS:C0087111